Correlation Between Biomx and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Biomx and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomx and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomx Inc and Kiromic Biopharma, you can compare the effects of market volatilities on Biomx and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomx with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomx and Kiromic Biopharma.
Diversification Opportunities for Biomx and Kiromic Biopharma
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biomx and Kiromic is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Biomx Inc and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Biomx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomx Inc are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Biomx i.e., Biomx and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Biomx and Kiromic Biopharma
If you would invest 268.00 in Kiromic Biopharma on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.56% |
Values | Daily Returns |
Biomx Inc vs. Kiromic Biopharma
Performance |
Timeline |
Biomx Inc |
Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biomx and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biomx and Kiromic Biopharma
The main advantage of trading using opposite Biomx and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomx position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.Biomx vs. ZyVersa Therapeutics | Biomx vs. Immix Biopharma | Biomx vs. Cns Pharmaceuticals | Biomx vs. Sonnet Biotherapeutics Holdings |
Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |